Literature DB >> 35657464

ASO Author Reflections: Disparities in Utilization of Curative-Intent Therapy for Veterans with Early-Stage HCC.

Michelle R Ju1, Patricio M Polanco2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35657464     DOI： 10.1245/s10434-022-11956-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  4 in total

1.  Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.

Authors:  Xiaotao Zhang; Hashem B El-Serag; Aaron P Thrift
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

2.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

3.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

4.  Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.

Authors:  Jessica A Davila; Jennifer R Kramer; Zhigang Duan; Peter A Richardson; Gia L Tyson; Yvonne H Sada; Fasiha Kanwal; Hashem B El-Serag
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.